Synopsis
Synopsis
0
VMF
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ancef
2. Cefamedin
3. Cefamezine
4. Cefazolin
5. Cephamezine
6. Cephazolin
7. Cephazolin Sodium
8. Cephazolin, Sodium
9. Gramaxin
10. Kefzol
11. Sodium Cephazolin
12. Sodium, Cefazolin
13. Sodium, Cephazolin
14. Totacef
1. Cefazolin Sodium Salt
2. 27164-46-1
3. Cefazoline Sodium
4. Ancef
5. Cefazil
6. Totacef
7. Kefzol
8. Sodium Cephazolin
9. Cefamedin
10. Gramaxin
11. Zolicef
12. Sodium Cefazolin
13. Cefacidal
14. Cephazolin Sodium
15. Cefazolin (sodium)
16. Monosodium Cefazolin
17. Sk&f 41558
18. Cefazolin Injection
19. Cefazolin And Dextrose
20. Cefazina
21. Firmacef
22. Liviclina
23. Atirin
24. Acef
25. Chebi:3483
26. Mls000028706
27. Nsc-291561
28. P380m0454z
29. Biazolina
30. Smr000058708
31. Skf 41558
32. Sk&f-41558
33. Sodium Cez
34. Cefazolin Sodium 100 Microg/ml In Acetonitrile/water
35. Ancef In Plastic Container
36. Cefabiozim
37. Cefalomicina
38. Lampocef
39. Neofazol
40. Zolisint
41. Recef
42. Zolin
43. Bor-cefazol
44. Cez Sodium
45. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1h-tetrazol-1-yl)acetyl)amino)-, Monosodium Salt (6r-trans)-
46. Monosodium (6r,7r)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1h-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
47. Lilly 46083
48. Unii-p380m0454z
49. Cefazolin Sodium [usan:usp:jan]
50. Sodium;(6r,7r)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
51. Prestwick_975
52. Einecs 248-278-4
53. Monosodium Cephazolin
54. Mfcd00056883
55. Ancef (tn)
56. Nsc 291561
57. Opera_id_1323
58. Ancef In Dextrose 5% In Plastic Container
59. Schembl40735
60. Spectrum1500164
61. Cefazolin Sodium [jan]
62. Cefazolin Sodium (jp17/usp)
63. Sodium Cez; Skf-41558
64. Cefazolin Sodium [usan]
65. Cefazolin Sodium [vandf]
66. Chembl1200523
67. Hms500a16
68. Ancef In Sodium Chloride 0.9% In Plastic Container
69. Cefazolin Sodium [mart.]
70. Cefazolin Sodium [who-dd]
71. Dtxsid901015786
72. Hms1570c14
73. Hms1920k07
74. Hms2091a10
75. Hms2097c14
76. Hms2230i22
77. Hms3260h10
78. Hms3714c14
79. Cefazolin Sodium Salt [mi]
80. Hy-b1078
81. Tox21_500274
82. Bdbm50247885
83. Ccg-40011
84. S4595
85. Akos015895533
86. Cefazolin Sodium [orange Book]
87. Cefazolin Sodium [ep Monograph]
88. Cs-4634
89. Lp00274
90. Cefazolin Sodium [usp Monograph]
91. Cefazolin Sodium Salt, 89.1-110.1%
92. Ncgc00093731-01
93. Ncgc00260959-01
94. 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-7-(2-(1h-tetrazol-1-yl)acetamido)-3-cephem-4-carboxylate
95. Ac-13166
96. Ac-31729
97. As-12230
98. Sodium (6r,7r)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1h-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
99. Eu-0100274
100. C 5020
101. C-2465
102. C08098
103. D00905
104. Q27106104
105. Cefazolin Sodium Salt, Antibiotic For Culture Media Use Only
106. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1h-tetrazol-1-yl)acetyl)amino)-, (6r-trans)-, Sodium Salt
107. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1h-tetrazol-1-yl)acetyl]amino]-, Sodium Salt, (6r,7r)- (1:1)
108. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[[2-(1h-tetrazol-1-yl)acetyl]amino]-,(6r,7r)-,sodium
109. Sodium (6r,7r)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1h-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
110. Sodium (6r,7r)-7-(2-(1h-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
111. Sodium (6r,7r)-7-(2-(1h-tetrazol-1-yl)acetamido)-3-((5-methyl-1,3,4-thiadiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
112. Sodium (6r-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(1h-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
113. Sodium 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1h-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylate
114. Sodium 7beta-(1h-tetrazol-1-yl)acetamido-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
115. Sodium 7beta-[2-(1h-tetrazol-1-yl)-acetamido]-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
116. Sodium 7beta-[2-(1h-tetrazol-1-yl)acetamido]-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
Molecular Weight | 476.5 g/mol |
---|---|
Molecular Formula | C14H13N8NaO4S3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 7 |
Exact Mass | 476.01195873 g/mol |
Monoisotopic Mass | 476.01195873 g/mol |
Topological Polar Surface Area | 238 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 746 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 8 | |
---|---|
Drug Name | Ancef in plastic container |
Active Ingredient | Cefazolin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 20mg base/ml; eq 10mg base/ml |
Market Status | Prescription |
Company | Baxter Hlthcare |
2 of 8 | |
---|---|
Drug Name | Cefazolin and dextrose |
Active Ingredient | Cefazolin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2gm base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | B Braun |
3 of 8 | |
---|---|
Drug Name | Cefazolin sodium |
Drug Label | CEFAZOLIN FOR INJECTION is a semi-synthetic cephalosporin for parenteral administration. It is the sodium salt of 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]-methyl}-8-oxo-7-[2-(1H-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxy... |
Active Ingredient | Cefazolin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 20gm base/vial; eq 100gm base/vial; eq 500mg base/vial; eq 10gm base/vial; eq 300gm base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | Acs Dobfar; Hospira; Steri Pharma; Hikma Farmaceutica; Samson Medcl; Sandoz |
4 of 8 | |
---|---|
Drug Name | Kefzol |
Active Ingredient | Cefazolin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial; eq 10gm base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | Acs Dobfar |
5 of 8 | |
---|---|
Drug Name | Ancef in plastic container |
Active Ingredient | Cefazolin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 20mg base/ml; eq 10mg base/ml |
Market Status | Prescription |
Company | Baxter Hlthcare |
6 of 8 | |
---|---|
Drug Name | Cefazolin and dextrose |
Active Ingredient | Cefazolin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 2gm base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | B Braun |
7 of 8 | |
---|---|
Drug Name | Cefazolin sodium |
Drug Label | CEFAZOLIN FOR INJECTION is a semi-synthetic cephalosporin for parenteral administration. It is the sodium salt of 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)thio]-methyl}-8-oxo-7-[2-(1H-tetrazol-1-yl)acetamido]-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxy... |
Active Ingredient | Cefazolin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 20gm base/vial; eq 100gm base/vial; eq 500mg base/vial; eq 10gm base/vial; eq 300gm base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | Acs Dobfar; Hospira; Steri Pharma; Hikma Farmaceutica; Samson Medcl; Sandoz |
8 of 8 | |
---|---|
Drug Name | Kefzol |
Active Ingredient | Cefazolin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial; eq 10gm base/vial; eq 1gm base/vial |
Market Status | Prescription |
Company | Acs Dobfar |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13741
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14133
Submission : 1999-05-03
Status : Active
Type : II
Certificate Number : R1-CEP 1999-074 - Rev 09
Issue Date : 2016-07-28
Type : Chemical
Substance Number : 988
Status : Valid
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-09-15
Pay. Date : 2013-09-06
DMF Number : 21982
Submission : 2008-09-10
Status : Active
Type : II
NDC Package Code : 51810-001
Start Marketing Date : 2008-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24527
Submission : 2011-01-04
Status : Inactive
Type : II
Registration Number : 301MF10089
Registrant's Address : No. 88 Yangzi Road, Economic & Technological Development Zone, Shijiazhuang City, Hebei Province
Initial Date of Registration : 2019-11-11
Latest Date of Registration : --
Registrant Name : Youngjin Pharmaceutical Co., Ltd.
Registration Date : 2022-12-30
Registration Number : 20201012-211-J-478(4)
Manufacturer Name : CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co.,Ltd.
Manufacturer Address : No.88 Yangzi Road, Economic & Technological Development Zone, Shijiazhuang City, Hebei Province China
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9480
Submission : 1991-12-16
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13797
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13707
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13750
Submission : 1998-09-01
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?